Condensed Statements of Comprehensive Income (Loss) - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Condensed Statements of Comprehensive Income (Loss) [Abstract]
Sales	$ 424,889	$ 341,264
Cost of sales (excluding depreciation expense)	158,606	117,266
Operating expenses:
Research and development	1,309,401	2,968,472
Sales and marketing	1,315,755	908,567
General and administrative	1,782,390	1,722,713
Depreciation and amortization	82,270	84,853
Total operating expenses	4,489,816	5,684,605
Loss from operations	(4,223,533)	(5,460,607)
Other income (expense):
Interest income	49,827	19,029
Change in fair value of conversion option liability	1,513,413	0
Change in fair value of warrants liabilities	3,683,000	0
Interest expense	(176,607)	(459,449)
Total other income (expense), net	5,069,633	(440,420)
Income (loss) before income taxes	846,100	(5,901,027)
Income tax benefit	0	(4,188)
Net income (loss)	846,100	(5,896,839)
Net income (loss) attributable to common stockholders, basic	328,646	(5,896,839)
Net income (loss) attributable to common stockholders, diluted	$ 328,646	$ (5,896,839)
Earnings (losses) per share:
Basic earnings per share (in Dollars per share)	$ 0	$ (0.23)
Diluted earnings per share (in Dollars per share)	$ 0	$ (0.23)
Weighted average common shares outstanding:
Basic (in Shares)	66,645,591	25,149,236
Diluted (in Shares)	78,095,633	25,149,236